Saudi - Delayed Quote SAR

Arabian International Healthcare Holding Company (9530.SR)

Compare
40.80 +1.00 (+2.51%)
At close: November 28 at 3:17 PM GMT+3
Loading Chart for 9530.SR
DELL
  • Previous Close 39.80
  • Open 39.60
  • Bid 40.65 x --
  • Ask 40.60 x --
  • Day's Range 39.00 - 40.80
  • 52 Week Range 35.50 - 44.40
  • Volume 3,843
  • Avg. Volume 4,860
  • Market Cap (intraday) 816M
  • Beta (5Y Monthly) 0.63
  • PE Ratio (TTM) 27.20
  • EPS (TTM) 1.50
  • Earnings Date --
  • Forward Dividend & Yield 1.00 (2.56%)
  • Ex-Dividend Date Jun 19, 2023
  • 1y Target Est --

Arabian International Healthcare Holding Company sells medical devices and consumables in the Kingdom of Saudi Arabia. The company operates through three segments: Medical Devices, Medical Supplies, and Clinical & Pharmaceutical. It offers various products for cardiology, intensive care, oncology, rehab, infection prevention technologies, hospital infrastructure, gene sequencing laboratory, anesthesia machines, hospital beds and medical furniture, lab furniture solution, biobanking solution, hospital information technology, surgical rooms solutions, laboratories, and filter ventilation system. The company also provides medical services at clinics; and sells health and beauty related medicines. The company was founded in 1973 and is headquartered in Riyadh, Saudi Arabia.

www.tibbiyah.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 9530.SR

View More

Performance Overview: 9530.SR

Trailing total returns as of 11/28/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

9530.SR
1.49%
Tadawul All Shares Index
2.44%

1-Year Return

9530.SR
2.00%
Tadawul All Shares Index
5.06%

3-Year Return

9530.SR
44.11%
Tadawul All Shares Index
3.03%

5-Year Return

9530.SR
44.11%
Tadawul All Shares Index
48.24%

Compare To: 9530.SR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 9530.SR

View More

Valuation Measures

Annual
As of 11/28/2024
  • Market Cap

    816.00M

  • Enterprise Value

    1.27B

  • Trailing P/E

    27.20

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.07

  • Price/Book (mrq)

    2.94

  • Enterprise Value/Revenue

    1.66

  • Enterprise Value/EBITDA

    13.06

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.89%

  • Return on Assets (ttm)

    2.18%

  • Return on Equity (ttm)

    9.64%

  • Revenue (ttm)

    765.06M

  • Net Income Avi to Common (ttm)

    29.79M

  • Diluted EPS (ttm)

    1.50

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    75.81M

  • Total Debt/Equity (mrq)

    161.84%

  • Levered Free Cash Flow (ttm)

    -9.91M

Research Analysis: 9530.SR

View More

Company Insights: 9530.SR

Research Reports: 9530.SR

View More

People Also Watch